Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Osawa M, Matsuda Y, Kinoshita Y, Wakai T, et al. Urokinase-type Plasminogen Activator Is a Therapeutic Target for Overcoming Sorafenib Resistance in Hepatoma Cells. Anticancer Res 2021;41:645-660.
PMID: 33517269


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016